ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Cue Health Receives Singapore HSA Authorization for its Molecular COVID-19 Test for Self-Testing
December 02, 2021Cue Health ("Cue") (Nasdaq: HLTH), a healthcare technology company, today announced it received Pandemic Special Access Route (PSAR) authorization from the Health Sciences Authority (HSA) for the Cue COVID-19... -
FDA Authorizes Cue Health's COVID-19 Test for At-Home, OTC Use
March 12, 2021Cue Health has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for over-the-counter (OTC) sale of its fast, accurate, COVID-19 test, making it the nation's first molecular diagnostic test available to ...
Pharma Sources Insight January 2025
